Celgene (CELG) Tops Q4 EPS by 2c, Offers FY17 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Celgene Reports Fourth Quarter and Full-Year 2016 Operating and Financial Results
January 26, 2017 7:30 AM ESTNet Product Sales $2.98B in Q4:16; Increased 17% Y/Y Net Product Sales $11.18B in 2016; Increased 22% Y/Y 2017 Guidance for Net Product Sales and Diluted EPS
SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) reported operating results for the fourth quarter and full-year of 2016. For the fourth quarter of 2016, net product sales were $2,977 million, an increase of 17 percent, year-over-year. Net product sales growth includes a 0.3 percent negative impact from currency exchange effects. Fourth quarter total revenue increased 16 percent... More
